<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Clinical Trials | Michigan Amyloid Program</title>
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet" />
  <style>
    body { font-family: 'Segoe UI', sans-serif; }
    .container { padding-top: 3rem; padding-bottom: 3rem; }
    .trial-card { border: 1px solid #ccc; border-radius: 0.5rem; padding: 1.5rem; margin-bottom: 2rem; background-color: #f8f9fa; }
    .trial-card h5 { color: #00274C; }
    .trial-card a { text-decoration: none; }
  </style>
</head>
<body>
  <div class="container">
    <h1 class="mb-4">Active Clinical Trials</h1>
    <p>The Michigan Amyloid Program offers access to cutting-edge clinical trials for patients with amyloidosis. Below are some current opportunities actively enrolling at Michigan Medicine:</p>

    <div class="trial-card">
      <h5>Phase 2 Study of Investigational Drug B in AL Amyloidosis</h5>
      <p><strong>Condition:</strong> Systemic AL Amyloidosis</p>
      <p>This phase 2 trial investigates the safety and response rates of Drug B in patients with relapsed or refractory AL amyloidosis. Includes MRD monitoring and biomarker analysis.</p>
      <p><strong>Status:</strong> Recruiting</p>
      <a href="https://clinicaltrials.gov/ct2/show/NCT12345678" target="_blank">View on ClinicalTrials.gov</a>
    </div>

    <div class="trial-card">
      <h5>Natural History Registry for Transthyretin (ATTR) Amyloidosis</h5>
      <p><strong>Condition:</strong> Hereditary and Wild-Type ATTR</p>
      <p>A non-interventional study collecting long-term outcomes and treatment history in patients with confirmed ATTR amyloidosis. Includes periodic cardiac and neurologic assessments.</p>
      <p><strong>Status:</strong> Enrolling by Invitation</p>
      <a href="https://clinicaltrials.gov/ct2/show/NCT98765432" target="_blank">View on ClinicalTrials.gov</a>
    </div>

    <div class="trial-card">
      <h5>Multi-Arm Platform Trial for Amyloid Neuropathy</h5>
      <p><strong>Condition:</strong> Amyloid Peripheral Neuropathy</p>
      <p>This adaptive study compares multiple agents targeting nerve involvement in systemic amyloidosis. Open to patients with confirmed nerve-predominant disease or autonomic symptoms.</p>
      <p><strong>Status:</strong> Not Yet Recruiting</p>
      <a href="https://clinicaltrials.gov/ct2/show/NCT24681012" target="_blank">View on ClinicalTrials.gov</a>
    </div>

    <p class="text-muted"><small>Questions? <a href="/contact.html">Contact the program</a> for eligibility and referral information.</small></p>
  </div>
</body>
</html>
